Skip to main content

Advertisement

SpringerLink
Log in

Review of resistant hypertension

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Despite the prevalence of hypertension, blood pressure (BP) can be controlled with effective therapy in most patients. However, in a small percentage of the hypertensive population, BP remains refractory to therapeutic measures. In such patients who have so-called “istant” hypertension, proper evaluation and assessment have to be undertaken to improve the BP control. There are some situations or factors that may make hypertension control difficult in some patients. Therefore, it is necessary to identify possible reasons for the loss of BP control and rectify them to achieve normotension. In addition to indicated work-up for secondary causes, aggressive treatment (nonpharmacologic and pharmacologic) of hypertension is required to prevent excessive morbidity and mortality in this special population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Thibonnier M: Ambulatory blood pressure monitoring: When is it warranted? Postgrad Med 1992, 91:263–274.

    PubMed  CAS  Google Scholar 

  2. Veglio F, Rabbia F, Riva P, et al.: Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension. Clin Exp Hypertens 2001, 23:203–211.

    Article  PubMed  CAS  Google Scholar 

  3. Verdecchia P: Using out of office blood pressure monitoring in the management of hypertension. Curr Hypertens Rep 2001, 3:400–405.

    PubMed  CAS  Google Scholar 

  4. Messerli FH, Ventura HO, Amodeo C: Osler’s maneuver and pseudohypertension. N Engl J Med 1985, 312:1548–1551.

    Article  PubMed  CAS  Google Scholar 

  5. Mejia AD, Egan BM, Schork NJ, Zweifler AJ: Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatmentresistant hypertension. Ann Intern Med 1990, 112:270–277.

    PubMed  CAS  Google Scholar 

  6. Dustan HP, Tarazi RM, Bravo EL: Dependence of arterial pressure on intravascular volume in treated hypertensive patients. N Engl J Med 1972, 286:861–866.

    PubMed  CAS  Google Scholar 

  7. Fierro-Carrion G, Ram CVS: Nonsteriodal anti-inflammatory drugs (NSAIDs) and blood pressure. Am J Cardiol 1980, 80:775–776.

    Article  Google Scholar 

  8. Bloxham CA, Beevers DG, Walker JM: Malignant hypertension and cigarette smoking. Br Med J 1997, 1:581–583.

    Google Scholar 

  9. Lavie P, Hoffstein V: Sleep apnea syndrome: a possible contributing factor to resistant hypertension. Sleep 2001, 24:721–725.

    PubMed  CAS  Google Scholar 

  10. Tuomilehto J, Enlund H, Salonen JG, Nissinen A: Alcohol, patient compliance and blood pressure control in hypertensive patients. Scand J Soc Med 1984, 12:177–181.

    PubMed  CAS  Google Scholar 

  11. Van JaarsveldBC, Krijnen P, Derkx FH, et al.: Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens. J Hum Hypertens 2001, 15:669–676.

    Article  PubMed  CAS  Google Scholar 

  12. Addison C, Varney S, Coats A: The use of ambulatory blood pressure monitoring in managing hypertension according to different treatment guidelines. J Hum Hypertens 2001, 15:535–538.

    Article  PubMed  CAS  Google Scholar 

  13. Felmeden DC, Lip GY: Resistant hypertension and the Birmingham Hypertension Square. Curr Hypertens Rep 2001, 3:203–208.

    PubMed  CAS  Google Scholar 

  14. Nuesch R, Schroeder K, Dieterle T, et al.: Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ 2001, 323:142–146.

    Article  PubMed  CAS  Google Scholar 

  15. Chobanian AV, Bakris, GL, Black HR, et al.: Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heat, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003, 41:1206–1252. The latest report from the Joint National Committee, which includes a description of refractory hypertension.

    Article  CAS  Google Scholar 

  16. Graves J: Management of difficult-to-control hypertension. Mayo Clin Proc 2000, 75:278–284.

    Article  PubMed  CAS  Google Scholar 

  17. Setaro J, Black H: Refractory hypertension. N Engl J Med 1992, 327:534–547.

    Article  Google Scholar 

  18. Eraker S, Kirscht J, Becker M: Understanding and improving patient compliance. Ann Intern Med 1984, 100:258–268.

    PubMed  CAS  Google Scholar 

  19. Cuspidi C, Macca G, Sampieri L, et al.: High prevalence of Cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 2001, 19:2063–2070.

    Article  PubMed  CAS  Google Scholar 

  20. Sartori M, Calo LA, Mascagna V, et al.: Aldosterone and refractory hypertension: a prospective cohort study. Am J Hypertens 2006, 19:373–379.

    Article  PubMed  CAS  Google Scholar 

  21. Gaddam KK, Pratt-Ubunama MN, Calhoun DA: Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension. Expert Rev Cardiovasc Ther 2006, 4:353–359.

    Article  PubMed  CAS  Google Scholar 

  22. Calhoun DA: Use of aldosterone antagonists in resistant hypertension. Prog Cardiovasc Dis 2006, 48:387–396. A rationale for the application of aldosterone antagonists is discussed in this publication.

    Article  PubMed  CAS  Google Scholar 

  23. Wolk R, Somers VK: Obesity-related cardiovascular disease: implications of obstructive sleep apnea. Diabetes Obes Metab 2006, 8:250–260.

    Article  PubMed  CAS  Google Scholar 

  24. Drager LF, Pereira AC, Barreto-Filho JA, et al.: Phenotypic characteristics associated with hypertension in patients with obstructive sleep apnea. J Hum Hypertens 2006, 20:523–528. Provides a description of patients with resistant hypertension who have sleep apnea syndrome.

    Article  PubMed  CAS  Google Scholar 

  25. Norman D, Loredo JS, Nelesen RA, et al.: Effects of continuous positive airway pressure versus supplemental oxygen on 24 hour ambulatory blood pressure. Hypertension 2006, 47:840–845.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Texas Blood Pressure Institute, 1420 Viceroy Drive, 75235, Dallas, TX, USA

    C. Venkata S. Ram MD, MACP

Authors
  1. C. Venkata S. Ram MD, MACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ram, C.V.S. Review of resistant hypertension. Current Science Inc 8, 398–402 (2006). https://doi.org/10.1007/s11906-006-0085-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-006-0085-9

Keywords

Search

Navigation